Загрузка...
Association between Ophthalmic Timolol and Hospitalisation for Bradycardia
Introduction. Ophthalmic timolol, a topical nonselective beta-blocker, has the potential to be absorbed systemically which may cause adverse cardiovascular effects. This study was conducted to determine whether initiation of ophthalmic timolol was associated with an increased risk of hospitalisation...
Сохранить в:
| Опубликовано в: : | J Ophthalmol |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Hindawi Publishing Corporation
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4385589/ https://ncbi.nlm.nih.gov/pubmed/25874117 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/567387 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|